Amrita Ahluwalia
British pharmacologist

Amrita Ahluwalia is a prominent British pharmacologist known for her research in the field of cardiovascular pharmacology. She is a professor at Queen Mary University of London and has made significant contributions to the understanding of the role of nitric oxide and nitrates in cardiovascular health.
Early Life and Education[edit]
Amrita Ahluwalia was born in the United Kingdom. She pursued her undergraduate studies in pharmacology at a leading British university, where she developed a keen interest in cardiovascular research. She went on to complete her PhD in pharmacology, focusing on the mechanisms of vascular regulation.
Career[edit]
Ahluwalia began her academic career as a lecturer in pharmacology, quickly rising through the ranks due to her innovative research and teaching excellence. She joined Queen Mary University of London, where she currently holds a professorship in vascular pharmacology.
Research Contributions[edit]
Ahluwalia's research has primarily focused on the role of nitric oxide in the cardiovascular system. Her work has elucidated the pathways through which nitric oxide and related compounds, such as nitrates, exert protective effects on the cardiovascular system. This research has important implications for the treatment of hypertension and other cardiovascular diseases.
She has also explored the therapeutic potential of dietary nitrates, found in foods like beetroot, in improving cardiovascular health. Her studies have demonstrated that dietary nitrates can lower blood pressure and improve vascular function, offering a potential non-pharmacological approach to managing cardiovascular risk.
Awards and Honors[edit]
Throughout her career, Ahluwalia has received numerous awards for her contributions to pharmacology and cardiovascular research. She is a fellow of several prestigious scientific societies and has been recognized for her work in advancing the understanding of vascular biology.
Teaching and Mentorship[edit]
In addition to her research, Ahluwalia is dedicated to teaching and mentoring the next generation of scientists. She is involved in undergraduate and postgraduate education, where she shares her expertise in pharmacology and encourages students to pursue research careers.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian